Exasol : Präsentation Webcast Vorläufige Zahlen für das Geschäftsjahr 2021

Investor Call on Preliminary Figures 2021

Aaron Auld (CEO), Jan-Dirk Henrich (CFO)

Feb. 16, 2022

Copyright © 2022 Exasol. All rights reserved.

Disclaimer

DISCLAIMER

This presentation contains future-oriented,forward-looking statements ("Forward- looking Statements"), estimates, opinions, projections and forecasts representing the current assessments and views with respect to anticipated future performance of Exasol AG. These assessments, views and Forward-looking Statements are subject to changes. There are uncertain conditions that are for the most part difficult to predict and are beyond the control of Exasol AG. Exasol AG is not under any obligation to publish any information resulting in changes in framework conditions or to publish revised information.

The information in this presentation as well as the Forward-looking Statements are of preliminary and abbreviated nature and may be subject to updating, revision and amendment, and such information may change materially. Neither Exasol AG nor any of its directors, officers, employees, agents or affiliates undertakes or is under any duty to update this presentation or to correct any inaccuracies in any such information which may become apparent or to provide any additional information.

The Forward-looking Statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "aims", "plans", "predicts", "may", "will" or "should" or, in each case, their negative, or other variations or comparable terminology. These Forward-looking Statements include all matters that are not historical facts. They appear in a number of places throughout this presentation and include statements regarding Exasol's intentions, beliefs or current expectations concerning, among other things, Exasol's prospects, growth, strategies, the industry in which it operates and potential or ongoing acquisitions. By their nature, Forward-looking Statements involve significant risks and uncertainties, because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking Statements should not be read as guarantees of future performance or results and will not necessarily be accurate indications of whether or not such results will be achieved.

2

Aaron Auld, CEO	Jan-Dirk Henrich, CFO/COO
• CEO at Exasol AG since July 2013	• CFO/COO at Exasol AG since September 2021
• Responsible for the strategic direction of the	• Responsible for finance related departments
company, communications as well as key	including Accounting, Controlling,
business relationships	Legal/Compliance and Investor Relations as
	well as Human Resources and Internal IT

3

Summary of key points

FINANCIALS 2021

(preliminary and unaudited)

ARR: 30.5m€

(+29%)

Revenue: 27.5m€

(+17%)

Adj. EBITDA: -30.9m€

(2020: -8.7m€)

Liquid Funds: 27.2m€

(2020: 69.5m€)

• Annual Recurring Revenue (ARR) of 30.5m EUR in 2021, up 29% vs 2020 on a like-for-like basis
• Revised outlook for 2021 (30-31m EUR ARR) achieved
• Revenue came in at 27.5m EUR, up 16.6 % vs. 2020
• Adj. EBITDA decreased to -30.9m EUR (2020: -8.7m EUR) after fast ramp up in Jan.-Sept. 2021
• Reorganisation executed in Oct. 2021 already bearing fruit: EBITDA in Q4 2021 at -7.9m EUR (incl. 1m EUR one- offs) compared to -8.7m EUR in Q3 2021
• Liquid assets stood at 27.2m EUR at end of 2021 providing enough headroom to meet mid-term targets

Outlook 2022+

• ARR/AAC to grow to 38.5 to 40.0m EUR at constant FX in 2022
• Adj. EBITDA to improve significantly to -14 to -16m EUR
• Liquid Funds to stand at 10 to 12m EUR end of 2022
• Operating cash break-even to be reached in the course of 2023
• ARR/AAC to grow to 100m EUR in the course of 2025 without further equity injection

4

Continued ability to convert and upsell large-scale data players in key verticals

Financial services

Industry

Healthcare

New customers since 2021 (examples)

+

Strong upsell performance with existing customers (examples)

Multinational banking Corp., UK 15bn USD rev./a

Multinational insurance Corp., DACH 10bn EUR rev./a

Multinational re-insurance Corp., DACH 24bn EUR rev./a

One of the biggest global conglomerates, US 70bn EUR rev./a

80 customers (> 37% of total)

increased their business with

Multinational Pharma Corp., DACHExasol in the past 12 months 18bn EUR rev./a

5